Business
Profusa Announces Listing Transfer to The Nasdaq Capital Market
BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces that, effective May 15, 2026, the Company will now be listed on The Nasdaq Capital Market. The move is the first of a previously announced series of interim milestones as laid out by the Nasdaq Hearings Panel to ensure continued complian
About this update from Profusa, Inc.
[{"type":"image","alt":"Profusa, Inc.","displaySize":"","headline":null,"caption":"Profusa, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":200,"height":71,"url":"https://media.zenfs.com/en/globenewswire.com/8f79cba194228307ca23a2955a9ec150"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/k9W1GpBMjzASO6xxhWH6Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTEyOA--/https://media.zenfs.com/en/globenewswire.com/8f79cba194228307ca23a2955a9ec150","width":200,"height":71},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/k9W1GpBMjzASO6xxhWH6Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTEyOA--/https://media.zenfs.com/en/globenewswire.com/8f79cba194228307ca23a2955a9ec150","width":200,"height":71}},"lazy":false},{"type":"text","content":"BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces that, effective May 15, 2026, the Company will now be listed on The Nasdaq Capital Market.","length":371,"tagName":"p"},{"type":"text","content":"The move is the first of a previously announced series of interim milestones as laid out by the Nasdaq Hearings Panel to ensure continued compliance with the bid price and stockholders’ equity requirements for continued listing on the Capital Market tier.","length":255,"tagName":"p"},{"type":"text","content":"About ProfusaBased in Berkeley, CA, Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.","length":582,"tagName":"p"},{"type":"text","content":"“LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa, Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.","length":169,"tagName":"p"},{"type":"text","content":"For more information, visit https...